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Efficacy of Hospital Cleaning Agents and Germicides
Against Epidemic Clostridium difficile Strains
Warren N. Fawley, PhD; Sarah Underwood, BSc; Jane Freeman, PhD; Simon D. Baines, PhD;
Katie Saxton, BSc; Keith Stephenson, PhD; Robert C. Owens, Jr., MD; Mark H. Wilcox, MD
objective. To compare the effects of hospital cleaning agents and germicides on the survival of epidemic Clostridium difficile strains.
methods. We compared the activity of and effects of exposure to 5 cleaning agents and/or germicides (3 containing chlorine, 1 containing
only detergent, and 1 containing hydrogen peroxide) on vegetative and spore forms of epidemic and non-epidemic C. difficile strains (3
of each). We carried out in vitro exposure experiments using a human fecal emulsion to mimic conditions found in situ.
results. Cleaning agent and germicide exposure experiments yielded very different results for C. difficile vegetative cells, compared with
those for spores. Working-strength concentrations of all of the agents inhibited the growth of C. difficile in culture. However, when used
at recommended working concentrations, only chlorine-based germicides were able to inactivate C. difficile spores. C. difficile epidemic
strains had a greater sporulation rate than nonepidemic strains. The mean sporulation rate, expressed as the proportion of a cell population
that is in spore form, was 13% for all strains not exposed to any cleaning agent or germicide, and it was significantly increased by exposure
to cleaning agents or germicides containing detergent alone (34%), a combination of detergent and hypochlorite (24%), or hydrogen
peroxide (33%). By contrast, the mean sporulation rate did not change substantially after exposure to germicides containing either a
combination of detergent and dichloroisocyanurate (9%) or dichloroisocyanurate alone (15%).
conclusions. These results highlight differences in the activity of cleaning agents and germicides against C. difficile spores and the
potential for some of these products to promote sporulation.
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Clostridium difficile remains the infective agent most com-
monly associated with hospital-acquired diarrhea. The num-
ber of reported cases of C. difficile infection in England, Wales,
and the United States has continued to increase, and rep-
resents a major burden on healthcare resources.1-4 Contam-
inated environmental surfaces and transient hand carriage by
healthcare workers and patients are important sources for C.
difficile transmission in hospitals.5-7 Notably, C. difficile spores
are known to be resistant to many commonly used germicides
and can persist for many months in hospital environments.8
Despite such evidence, few data exist on how best to decon-
taminate the hospital environment.9
C. difficile strains can be separated into distinct types, by
multiple methods of genetic fingerprinting. Crucially, epi-
demiological studies have identified specific predominant C.
difficile phenotypes and genotypes. Polymerase chain reaction
(PCR) ribotype 001 has been reported to be present in 33 of
58 UK hospitals, and is also prevalent in multiple other coun-
tries, including Sweden, the United States and Japan.10-13 Sim-
ilarly, serogroup C isolates (corresponding to PCR ribotype
012)14 have been reported to be strongly associated with out-
breaks of C. difficile–associated disease in Belgium and
France.15,16 More recently, widespread outbreaks have been
associated with a previously uncommon C. difficile strain,
PCR ribotype 027 (also known as NAP 1, North American
PFGE type 1), in the United States, Canada, the United King-
dom, and Europe.17-21 These findings suggest that some strains
of C. difficile have an increased propensity to cause disease
and possibly an increased propensity to persist in the envi-
ronment in healthcare institutions.
We have demonstrated that the choice of hospital decon-
tamination protocols can markedly affect the prevalence and
environmental distribution of C. difficile contamination.7
Also, the sporulation rate of PCR ribotype 001 can be en-
hanced when this strain is exposed to some, but not all,
hospital cleaning agents or germicides.22 We aimed to extend
these findings by comparing the activity of and effects of
exposure to cleaning agents or germicides on the vegetative
and spore forms of epidemic and nonepidemic C. difficile
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table. Cleaning Agents and/or Germicides Used in the Study







Anionic surfactant and NaDCC Chlor-clean Guest Medical 1,000 ppm chlorine 1/4
Nonionic surfactant and phosphate Hospec Youngs Detergents 0.10% 1/16
Detergent and NaOCl Dispatch Caltech Industries 5,500 ppm NaOCl 1/64
Hydrogen peroxide G-Force JohnsonDiversey 1 : 64 dilutionb 1/128
NaDCC Sanichlor Ecolab 1,000 ppm chlorine 1/4
note. MIC, minimum inhibitory concentration; NaDCC, sodium dichloroisocyanurate; NaOCl, hypochlorite.
a According to manufacturer’s guidelines.
b Concentration of hydrogen peroxide not stated by the manufacturer.
strains. To mimic conditions found in situ we carried out the
exposure experiments using a human fecal emulsion.
methods
Selection of Test Strains
We examined 6 C. difficile strains of diverse origin, which
were as follows: 2 epidemic PCR ribotype 027 strains from
a Canadian-US outbreak (Maine Medical Center; strain A)
and a UK outbreak (Stoke Mandeville Hospital; strain B); a
UK epidemic PCR ribotype 001 strain (strain C); a nonep-
idemic UK PCR ribotype 078 strain (strain D); a nonepidemic
strain isolated in Canada and the United States (strain E);
and a nontoxigenic PCR ribotype 010 strain isolated in UK
hospital environments (strain F).
Determination of Minimum Inhibitory
Concentrations (MICs)
Strains were cultured anaerobically in Schaedler’s anaerobic
broth at 37C for 24 hours. Standardized inocula were then
inoculated at multiple points onto Wilkins-Chalgren agar that
contained doubling dilutions of 1 of 5 commonly-used clean-
ing chemicals: anionic surfactant and sodium dichloroiso-
cyanurate (NaDCC; Chlor-clean; Guest Medical), nonionic
surfactant and phosphate (Hospec; Youngs Detergents), de-
tergent and hypochlorite (NaOCl; Dispatch; Caltech Indus-
tries), hydrogen peroxide (H2O2; G-Force; JohnsonDiversey),
and NaDCC alone (Sanichlor; Ecolab) (all agents were tested
at a range of dilutions from 1/1,024 of the manufacturer’s
recommended working strength to 1/4 of the manufacturer’s
recommended working strength) (Table). Agar plates were
examined following anaerobic incubation at 37C for 48
hours. The MIC was defined as the lowest concentration of
cleaning agent or germicide that prevented visible bacterial
growth.
Spore Viability Assay
Mature spores from the 6 C. difficile strains tested were pre-
pared as described by Baines et al.23 and were added to mul-
tiple 5-mL aliquots of water containing one of the hospital
cleaning agents and/or germicides at a working strength con-
centration (Table). Duplicate aliquots were sampled after 0,
10, 20, and 30 minutes of contact time by vacuum filtering
using 0.22-mm grade nylon filters (Microfil V apparatus; Mil-
lipore). The filters were washed with 50 mL of sterile water
to remove residual cleaning agent and/or germicide, and then
placed onto Brazier’s cycloserine cefoxitin egg yolk agar sup-
plemented with 5 mg/L lysozyme and 2% lysed horse blood
(CCEYL agar; Bioconnections). We enumerated spore ger-
mination after anaerobic incubation at 37C for 48 hours. A
single C. difficile colony was considered evidence of germi-
nation from a single spore. Results were interpreted with
respect to the viability of spores preparations exposed to a
cleaning agent and/or germicide, compared nonexposed con-
trol preparations.
Sporulation Assay
Fecal samples from 5 healthy volunteers were pooled, emul-
sified, and centrifuged progressively, until the emulsion
passed through a 0.22-mm filter. The 6 C. difficile strains were
grown overnight in Schaedler’s anaerobic broth, and then 100
mL of each culture was transferred into 5 prepared fecal emul-
sions, each containing a subinhibitory concentration (0.25
#MIC for each strain) of 1 of the 5 cleaning agents and/or
germicides (Table). Following incubation at 37C for 72 hours
in an anaerobic environment, duplicate samples were air-
dried on glass slides and stained using a malachite green–
carbol fuchsin spore stain. Spores were counted by light mi-
croscopy and expressed as a percentage of total cells (there
were 5 fields per slide, each of 100 cells). Each culture was
performed in duplicate. Cultures containing no cleaning
agents or germicides were included as experimental controls.
The sporulation data were examined by 2-way analysis of
variance to determine significant differences.
results
MICs for C. difficile Strains
The MICs of the 5 cleaning agents and/or germicides for C.
difficile strains A-F are shown in the Table. Growth of C.
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figure 1. Mean spore germination rates for 5 strains of Clostridium difficile exposed to 5 commonly used hospital cleaning agents
and/or germicides at manufacturer’s recommended concentrations. X, anionic surfactant and sodium dichloroisocyanurate; triangles, non-
ionic surfactant and phosphate; open circles, detergent and hypochlorite; squares, hydrogen peroxide; closed circles, sodium dichloroisocy-
anurate; dashed line, control (no cleaning agent). CFU, colony-forming units; PCR, polymerase chain reaction.
difficile vegetative cells was inhibited by all of the cleaning
agents and/or germicides tested at concentrations markedly
below the working strength recommended by their respective
manufacturers. The agent containing hypochlorite (Dispatch)
was found to be the most active antimicrobial among the
chlorine-containing products; it was active against vegetative
C. difficile at an equivalent of 86 ppm of available chlorine;
for both agents containing dichloroisocyanurate (Sanichlor
and Chlor-clean), approximately 250 ppm of available chlo-
rine was required to inhibit C. difficile growth. The nonan-
ionic surfactant cleaning agent (Hospec) prevented C. difficile
vegetative growth at a 16-fold dilution of the recommended
working strength, while the agent containing hydrogen per-
oxide (G-Force) remained inhibitory at a 128-fold dilution
of its recommended working strength.
Efficacy Against Spore Germination
The reduction in the germination rate of spores in C. difficile
strains A-F after exposure to each of the 5 cleaning agents
and/or germicides was measured in comparison with controls
(strains which had no exposure to cleaning agents or ger-
micides). The results are shown in Figure 1. All of the chlo-
rine-containing agents (Chlor-clean, Dispatch, and Sanichlor)
caused an immediate, complete prevention of spore germi-
nation. By contrast, exposure to either neutral detergent
(Hospec) or hydrogen peroxide (G-Force) was not associated
a with significant reduction in spore germination; hence, the
numbers of viable spores after 30 minutes of exposure to
either of these agents did not differ significantly from those
for controls. No discernible differences in the spore survival
efficacy of cleaning agents against epidemic c. difficile strains 923
figure 2. Mean sporulation rates for 6 Clostridium difficile strains exposed to subinhibitory concentrations of 5 commonly used hospital
cleaning agents and/or germicides. Two-way analysis of variance was performed after angular transformation of data, followed by unplanned
comparison. Whiskers indicate minimum significant difference; no overlap between sets of whiskers represents a significant difference at
the 5% level. NaDCC, sodium dichloroisocyanurate.
rate of C. difficile epidemic strains were observed in com-
parison with that of nonepidemic strains.
Effect of Subinhibitory Concentrations on
Sporulation Rates
When cultured in fecal emulsion in the absence of a cleaning
agent or germicide, the sporulation rate of each epidemic C.
difficile strain (A, B, and C) was significantly greater than that
of the other strains tested. However, the sporulation rate of
strain C (PCR ribotype 001) was markedly greater than that
of all the other strains tested, both in the absence and in the
presence of a cleaning agent and/or germicide (Figure 2).
Mean sporulation capacity, expressed as the proportion of a
cell population that is in spore form, was 13% for all strains
not exposed to a cleaning agent or germicide, and it was
significantly increased by exposure to neutral detergent (Hos-
pec; 34%), a combination of detergent and hypochlorite (Dis-
patch; 24%), and hydrogen peroxide (G-Force; 33%). By con-
trast, exposure to dichloroisocyanurate-containing agents
(either Chlor-clean [9%] or Sanichlor [15%]) was generally
not associated with significant changes in sporulation. Spor-
ulation in response to cleaning agents or germicides was
higher for the C. difficile epidemic strains (especially in strain
C, PCR ribotype 001), compared with the other strains tested.
discussion
The contribution of the healthcare environment to infection
transmission is controversial. The best evidence that the en-
vironment is an important source of nosocomial infection
concerns bacteria that resist desiccation.24 The foremost path-
ogens, in terms of survival on environmental surfaces, are
spore-forming bacteria such as C. difficile. Although fecal soil-
ing of the environment may include vegetative cells, spores
of C. difficile predominate, especially after exposure to air and
drying.25 The activity of cleaning agents and/or germicides
on C. difficile epidemic strains, and particularly on spores,
has been poorly studied, and the few studies in this area have
usually only examined single strains.26-28
We found markedly different effects when C. difficile was
exposed to commonly used hospital cleaning agents and ger-
micides. Notably, tests involving exposure of C. difficile veg-
etative cells to cleaning agents and germicides yielded results
very different from those obtained in experiments with
spores. Working-strength concentrations of all of the cleaning
agents and germicides inhibited growth of C. difficile in cul-
ture. However, only chlorine-containing germicides inacti-
vated C. difficile spores. Neither hydrogen peroxide (G-Force)
nor nonionic surfactant with phosphate (Hospec) exerted any
discernible effect on C. difficile spores, despite prevention of
vegetative growth at 1/128 and 1/16 of the recommended
working strength, respectively. The resistance of bacterial
spores to nonionic surfactants is well established, and there-
fore the lack of activity against C. difficile spores was not
surprising.8 However, the poor efficacy of the hydrogen per-
oxide–containing agent demonstrated in the present study
was unexpected. Vaporized hydrogen peroxide has been de-
scribed for use as a sporicide,29 and therefore its lack of activity
against C. difficile spores is perhaps contradictory. The con-
centration of active hydrogen peroxide in the working
strength solution used in the present study is not stated by
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the manufacturer. It is, therefore, possible that the concen-
tration recommended for use contains insufficient germicide
to kill spores, and/or other chemicals present in G-Force may
reduce its sporicidal effectiveness.
These findings concur with the results of previous exper-
imental and ward-based studies. Wilcox et al.7 demonstrated
a significant correlation between the use of a chlorine-con-
taining (dichloroisocyanurate) germicide and reduction in C.
difficile infection incidence on 1 of 2 hospital wards that were
examined using a cross-over study design. Mayfield et al.30
reported a significant decrease in C. difficile infection cases
on a bone marrow transplant unit following implementation
of a hypochlorite-based cleaning regimen. Although environ-
mental prevalence of C. difficile was not measured, it is in-
teresting to note that the incidence of C. difficile infection
returned almost to the original level following the reintro-
duction of the original quaternary ammonium–compound
germicide.30 Kaatz and colleagues31 found that phosphate-
buffered hypochlorite (1,600 ppm of available chlorine; pH
7.6) was more effective than unbuffered hypochlorite (500
ppm of available chlorine) at reducing environmental con-
tamination by C. difficile.
We previously described the enhanced sporulation rate of
the epidemic C. difficile PCR ribotype 001 strain in response
to exposure to cleaning agents that did not contain chlorine.22
The clinical significance of this finding is unknown. However,
we have shown that in some settings, the environmental prev-
alence of C. difficile correlates with incidence of C. difficile
infection.22,32 In view of these findings and the environmental
decontamination intervention studies discussed above, it is
plausible that increased sporulation capacity, in response to
certain environmental stresses, may be associated with greater
spread or persistence in some C. difficile strains. Such stresses
include drying, exposure to air, and exposure to cleaning
agents and/or germicides. In the present study, we aimed to
simulate these stresses by exposing 6 C. difficile strains in fecal
emulsions to subinhibitory concentrations of cleaning agents
and/or germicides. The results confirm our earlier find-
ings,22 and furthermore show that other C. difficile epidemic
strains also had greater sporulation capacity than nonepi-
demic strains—notably when exposed to cleaning agents
and/or germicides that did not contain chlorine. Dichloro-
isocyanurate-containing agents generally did not promote
sporulation beyond that observed in control experiments. The
poor activity of the hydrogen peroxide–containing agent (G-
Force) against C. difficile spores was compounded by its
propensity to promote sporulation in epidemic strains when
they were exposed to a subinhibitory concentration of this
germicide.
Our results support the use of dichloroisocyanurate-con-
taining germicides to control C. difficile in healthcare insti-
tutions, in preference to the other agents tested. In our spore
viability assay, all 3 chlorine-containing agents inactivated
both vegetative cells and spores at the concentrations rec-
ommended by manufacturers. However, the hypochlorite-
containing compound (Dispatch) was the only chlorine-con-
taining agent tested that was associated with an increase in
mean sporulation capacity, when compared with the di-
chloroisocyanurate-containing compounds (Chlor-clean and
Sanichlor). Bloomfield and Uso demonstrated that dichlo-
roisocyanurate-containing agents are superior to hypochlo-
rite-containing compounds, being less susceptible to inacti-
vation by organic material.33 The use of chlorine-containing
products presents health and safety, cleaning, and materials
compatibility challenges, the risks of which need to be as-
sessed. However, the combined body of evidence suggests that
dichloroisocyanurate (ie, chlorine-release) germicides cur-
rently represent the optimum choice for the removal of C.
difficile from healthcare environments.
Removal or inactivation of C. difficile spores in the health-
care setting is believed to be an important control measure
for this increasingly prevalent pathogen. Our results suggest
that compounds that do not kill C. difficile spores at working
concentrations, such as general-purpose detergents and hy-
drogen peroxide, may promote the persistence and accu-
mulation of spores in healthcare environments. The envi-
ronmental cleaning of healthcare premises needs to be both
timely and efficient. Additionally, healthcare institutions
should ensure that cleaning agents and/or germicides with
adequate microbiological effectiveness are employed.
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